Vaccinates had significantly
lower lung lesions (P = 0.05) and concentrations of M. hyopneumoniae in the lungs (P = 0.05) as measured by PCR.7 There was also reduced shedding of M. hyopneumoniae, for the vaccinates, during the four - week post-challenge period.